Laxminarain Prattipati 4

What Happened
Laxminarain Prattipati, a director of Microbot Medical Inc. (MBOT), was granted 10,000 derivative shares (transaction code A — award/grant) on 2026-04-01. The shares were acquired at a $0.00 price (no cash paid), giving a reported acquisition value of $0 on the Form 4. This is an acquisition/award rather than an open-market purchase or sale.

Key Details

• Transaction date: 2026-04-01; Form 4 filed: 2026-04-03 (appears timely, within the two-business-day filing window).
• Transaction type/code: A (award/grant); classified as a derivative acquisition.
• Shares acquired: 10,000; price per share: $0.00; reported cash value: $0.
• Shares owned after transaction: Not specified on the reported Form 4.
• Notable footnotes: Filing does not specify the exact instrument (e.g., restricted stock vs. RSUs) or any tax-withholding/cashless details.

Context
Grants and awards are often part of compensation or director-adoption programs and differ from open-market purchases by insiders. While an award increases insider ownership, it does not necessarily reflect immediate trading intent or a personal cash investment. This Form 4 reports a derivative award rather than a sale and was filed promptly.